deferiprone has been researched along with Plasmodium falciparum Malaria in 5 studies
Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We conducted a prospective, double-blind, placebo-controlled, cross-over trial of deferiprone (L1; CP20; 1,2-dimethyl-3-hydroxypyridin-4-one) in 25 adult Zambians with asymptomatic Plasmodium falciparum parasitemia." | 9.08 | Assessment of the effect of the oral iron chelator deferiprone on asymptomatic Plasmodium falciparum parasitemia in humans. ( Biemba, G; Brittenham, GM; Fassos, FF; Gordeuk, VR; Koren, G; Mabeza, GF; McClelland, RA; Olivieri, NF; Parry, D; Thuma, PE; Zulu, S, 1998) |
| "Deferiprone (L1) seems to be a promising agent as an adjuvant in the treatment for severe P." | 6.70 | Deferiprone (L1) as an adjuvant therapy for Plasmodium falciparum malaria. ( Ghosh, K; Karnad, D; Mohanty, D; Pathare, AV, 2002) |
| " We conducted a prospective, double-blind, placebo-controlled, cross-over trial of deferiprone (L1; CP20; 1,2-dimethyl-3-hydroxypyridin-4-one) in 25 adult Zambians with asymptomatic Plasmodium falciparum parasitemia." | 5.08 | Assessment of the effect of the oral iron chelator deferiprone on asymptomatic Plasmodium falciparum parasitemia in humans. ( Biemba, G; Brittenham, GM; Fassos, FF; Gordeuk, VR; Koren, G; Mabeza, GF; McClelland, RA; Olivieri, NF; Parry, D; Thuma, PE; Zulu, S, 1998) |
| "Deferiprone (L1) seems to be a promising agent as an adjuvant in the treatment for severe P." | 2.70 | Deferiprone (L1) as an adjuvant therapy for Plasmodium falciparum malaria. ( Ghosh, K; Karnad, D; Mohanty, D; Pathare, AV, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maneekesorn, S | 1 |
| Chuljerm, H | 1 |
| Koonyosying, P | 1 |
| Uthaipibull, C | 1 |
| Ma, Y | 1 |
| Srichairatanakool, S | 1 |
| Mohanty, D | 2 |
| Ghosh, K | 1 |
| Pathare, AV | 1 |
| Karnad, D | 1 |
| Gordeuk, VR | 2 |
| Loyevsky, M | 1 |
| Thuma, PE | 1 |
| Olivieri, NF | 1 |
| Mabeza, GF | 1 |
| Biemba, G | 1 |
| Parry, D | 1 |
| Zulu, S | 1 |
| Fassos, FF | 1 |
| McClelland, RA | 1 |
| Koren, G | 1 |
| Brittenham, GM | 1 |
1 review available for deferiprone and Plasmodium falciparum Malaria
| Article | Year |
|---|---|
Antimalarial effect of iron chelators.
Topics: Animals; Antimalarials; Child; Deferiprone; Deferoxamine; Drug Therapy, Combination; Humans; In Vitr | 2002 |
2 trials available for deferiprone and Plasmodium falciparum Malaria
| Article | Year |
|---|---|
Deferiprone (L1) as an adjuvant therapy for Plasmodium falciparum malaria.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Antimalarials; Coma; Deferiprone; Double-Blind | 2002 |
Assessment of the effect of the oral iron chelator deferiprone on asymptomatic Plasmodium falciparum parasitemia in humans.
Topics: Administration, Oral; Adult; Area Under Curve; Cross-Over Studies; Deferiprone; Dose-Response Relati | 1998 |
2 other studies available for deferiprone and Plasmodium falciparum Malaria
| Article | Year |
|---|---|
Identifying a Deferiprone-Resveratrol Hybrid as an Effective Lipophilic Anti-Plasmodial Agent.
Topics: Antimalarials; Antioxidants; Deferiprone; Erythrocytes; Humans; Iron Chelating Agents; Malaria, Falc | 2021 |
Red cell adhesion in cerebral malaria.
Topics: Animals; Cell Adhesion; Deferiprone; Erythrocytes; Humans; Malaria, Cerebral; Malaria, Falciparum; P | 2007 |